Mobile App and Digital System for Patients After Myocardial Infarction

Telemedicine Clinical Trial

— afterAMI  

Official title:

The Impact of Mobile Application and a Digital Support System on the Prevention of Cardiovascular Events in Patients After a Myocardial Infarction.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04793425
• Other study ID #: WarsawMU1
• Status: Recruiting
• Phase: N/A
• Start date: December 1, 2020
• Est. completion date: July 2023

Study information

• Verified date: December 2020
• Source: Medical University of Warsaw
• Contact: Bartosz Krzowski, MD
• Phone: +48 791347820
• Email: bartosz.krzowski[@]wum.edu.pl
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The treatment of acute myocardial infarction (MI) in Poland is at the level of standardized European care. However, the first months after MI are crucial from the perspective of patient's prognosis. It is extremely important to take care of all cardiovascular risk factors.

Mobile application (afterAMI) supported by web system is a novel telemedical tool created to support patient and physician during the process of cardiac rehabilitation. The application has educational model with focus on cardiovascular risk factors and lifestyle after MI. Moreover, there is a module to control vital signs like blood pressure, heart rate, weight and many others. Additionally, application will send reminders for better drug adherence.

100 patients will be recruited to take part in the study. All of which will be hospitalized at the 1st Department and Clinic of Cardiology because of the MI. The aim of the project is to study the impact of application-supported model of care with comparison to standard care. At the end of the study cardiovascular risk factors control will be analysed, as well as rehospitalizations, patient's knowledge regarding risk factors, return to work and quality of life.

This will be a prospective, open-label, randomized, single-centre study. All 100 patients will be observed 6 months after discharge from the hospital. End points will be assessed during control visit 1- and 6-months after inclusion into the study.

This project is an example of a telemedicine solution application into everyday practice, which is consistent with multiple international cardiac societies.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: July 2023
• Est. primary completion date: December 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• signing the informed consent to participate in the study

• hospitalization due to myocardial infarction

• a mobile device with Internet access and the Android/iOS operating system

• age >17 years old

• positive results of the test verifying the basic skills of using mobile applications

Related Conditions & MeSH terms

• Infarction
• mHealth
• Myocardial Infarction
• Telemedicine

Intervention

Behavioral:
• Mobile application (afterAMI)
The rehabilitation process of the patients in the intervention group will be supported by the mobile application (afterAMI) with synchronized, dedicated web page. Patients in the intervention group will be given an access to educational data regarding their individualized diseases. Additionally every patient will receive regularly messages with notifications regarding lifestyle and adherence to the therapy. All reported vital signs (blood pressure, heart rate, weight and many more) will be analyzed every day and in case of need a short message will be sent to the patient with indication to go to the primary healthcare clinic/hospital. Additionally, application will send notifications with reminders to take drugs.

Locations

Country	Name	City	State
Poland	1st Department of Cariology of Medcial University of Warsaw	Warsaw	Mazowieckie

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Warsaw

Country where clinical trial is conducted

Poland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rehospitalization or urgent outpatient visit	The number and reasons of rehospitalizations and urgent outpatient visits.	This outcome will be assessed 1 month after discharge from the hospital.
Primary	Rehospitalization or urgent outpatient visit	The number and reasons of rehospitalizations and urgent outpatient visits.	This outcome will be assessed 6 months after discharge from the hospital.
Primary	Cardiovascular risk factors control - hypertension	Systolic and diastolic blood pressure values will be analyzed with special focus on meeting the values recommended by European Society of Cardiology guidelines.	This outcome will be assessed 1 month after discharge from the hospital.
Primary	Cardiovascular risk factors control - hypertension	Systolic and diastolic blood pressure values will be analyzed with special focus on meeting the values recommended by European Society of Cardiology guidelines.	This outcome will be assessed 6 months after discharge from the hospital.
Primary	Cardiovascular risk factors control - body mass	Body mass will be measured. Change [kg] from baseline body mass will be analyzed.	This outcome will be assessed 1 month after discharge from the hospital.
Primary	Cardiovascular risk factors control - body mass	Body mass will be measured. Change [kg] from baseline body mass will be analyzed.	This outcome will be assessed 6 months after discharge from the hospital.
Primary	Cardiovascular risk factors control - nicotinism	The number of patients who are active smokers will be assessed. The change from baseline will be analyzed.	This outcome will be assessed 1 month after discharge from the hospital.
Primary	Cardiovascular risk factors control - nicotinism	The number of patients who are active smokers will be assessed. The change from baseline will be analyzed.	This outcome will be assessed 6 months after discharge from the hospital.
Primary	Cardiovascular risk factors control - dyslipidemia	LDL cholesterol level will be measured and the change from baseline will be analyzed.	This outcome will be assessed 1 month after discharge from the hospital.
Primary	Cardiovascular risk factors control - dyslipidemia	LDL cholesterol level will be measured and the change from baseline will be analyzed.	This outcome will be assessed 6 months after discharge from the hospital.
Secondary	Quality of life - MacNew	Quality of life will be assessed with MacNew questionnaire.Scoring of the MacNew is straight-forward. The maximum possible score in any domain is 7 [high quality] and the minimum is 1 [poor quality]. The quality of life is assessed with regard to physical, emotional and social aspect, as well as general quality of life. There are 27 questions in total.	This outcome will be assessed 1 month after discharge from the hospital.
Secondary	Quality of life - MacNew	Quality of life will be assessed with MacNew questionnaire.Scoring of the MacNew is straight-forward. The maximum possible score in any domain is 7 [high quality] and the minimum is 1 [poor quality]. The quality of life is assessed with regard to physical, emotional and social aspect, as well as general quality of life. There are 27 questions in total.	This outcome will be assessed 6 months after discharge from the hospital.
Secondary	Quality of life - descriptive profile of a respondent's health state	Quality of life will be assessed with EQ-5D-5L questionnaire. The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group.; There are 5 aspects examined: mobility, self-care, usual activity, pain/discomfort, anxiety/depression. Every part is assessed based on 5 level scale: LEVEL 1: indicating no problem LEVEL 2: indicating slight problems LEVEL 3: indicating moderate problems LEVEL 4: indicating severe problems LEVEL 5: indicating unable to/extreme problems	This outcome will be assessed 1 month after discharge from the hospital.
Secondary	Quality of life - descriptive profile of a respondent's health state	Quality of life will be assessed with EQ-5D-5L questionnaire. The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group.; There are 5 aspects examined: mobility, self-care, usual activity, pain/discomfort, anxiety/depression. Every part is assessed based on 5 level scale: LEVEL 1: indicating no problem LEVEL 2: indicating slight problems LEVEL 3: indicating moderate problems LEVEL 4: indicating severe problems LEVEL 5: indicating unable to/extreme problems	This outcome will be assessed 6 months after discharge from the hospital.
Secondary	DASS 21 - Depression, anxiety and stress assessment	Depression, anxiety and stress assessment will be assessed with DASS 21 (Depression Anxiety Stress Scales) scale The DASS is a quantitative measure of distress along the 3 axes of depression, anxiety and stress.; There are 21 questions, each has 4 possible answers: 0 Did not apply to me at all - NEVER; Applied to me to some degree, or some of the time - SOMETIMES; Applied to me to a considerable degree, or a good part of time - OFTEN; Applied to me very much, or most of the time - ALMOST ALWAYS There are 7 questions assigned to every aspect: depression, anxiety and stress respectively.; Higher result in every section contributes to higher severity in depression, anxiety and stress.	This outcome will be assessed 1 month after discharge from the hospital.
Secondary	DASS 21 - Depression, anxiety and stress assessment	Depression, anxiety and stress assessment will be assessed with DASS 21 (Depression Anxiety Stress Scales) scale The DASS is a quantitative measure of distress along the 3 axes of depression, anxiety and stress.; There are 21 questions, each has 4 possible answers: 0 Did not apply to me at all - NEVER; Applied to me to some degree, or some of the time - SOMETIMES; Applied to me to a considerable degree, or a good part of time - OFTEN; Applied to me very much, or most of the time - ALMOST ALWAYS There are 7 questions assigned to every aspect: depression, anxiety and stress respectively.; Higher result in every section contributes to higher severity in depression, anxiety and stress.; Higher result in every section contributes to higher severity in depression, anxiety and stress.	This outcome will be assessed 6 months after discharge from the hospital.
Secondary	Cardiovascular risk factor knowledge	Cardiovascular risk factor knowledge will be assessed with previously prepared questionnaire (10 questions).; There are 9 single choice questions. Every correct answer is rewarded with a point. There is 1 open question, where the patient is asked to list known cardiovascular risk factors. Patient gets 1 point fo 1-2 CV risk factors, 2 points for 3-4 CV risk factors, 3 points for 5-6 CV risk factors and 4 points for >6 named CV risk factors.; The maximum score is 13 points , which indicates good cardiovascular risk factors knowledge. The minimum score is 0 points, which indicates poor cardiovascular risk factors knowledge.	This outcome will be assessed 1 month after discharge from the hospital.
Secondary	Cardiovascular risk factor knowledge	Cardiovascular risk factor knowledge will be assessed with previously prepared questionnaire (10 questions).; There are 9 single choice questions. Every correct answer is rewarded with a point. There is 1 open question, where the patient is asked to list known cardiovascular risk factors. Patient gets 1 point fo 1-2 CV risk factors, 2 points for 3-4 CV risk factors, 3 points for 5-6 CV risk factors and 4 points for >6 named CV risk factors.; The maximum score is 13 points , which indicates good cardiovascular risk factors knowledge. The minimum score is 0 points, which indicates poor cardiovascular risk factors knowledge.	This outcome will be assessed 6 months after discharge from the hospital.
Secondary	Return to work	In case of patients who were previously working the amount of patients who came back to work will be assessed.	This outcome will be assessed 1 month after discharge from the hospital.
Secondary	Return to work	In case of patients who were previously working the amount of patients who came back to work will be assessed.	This outcome will be assessed 6 months after discharge from the hospital.